{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:07:23Z","timestamp":1778684843487,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"the general project of National Key Research and Development Program of China","award":["2023YFC2706405"],"award-info":[{"award-number":["2023YFC2706405"]}]},{"name":"the general project of National Key Research and Development Program of China","award":["2022YFC2705300"],"award-info":[{"award-number":["2022YFC2705300"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2024-2-5082"],"award-info":[{"award-number":["2024-2-5082"]}]},{"name":"he key project of innovation cultivation fund of the Seventh Medical Center of Chinese PLA General Hospital","award":["QZX-2023-1"],"award-info":[{"award-number":["QZX-2023-1"]}]},{"name":"Innovation Talent Fund of Senior Department of Pediatrics, The Seventh Medical Center of PLA General Hospital","award":["QZX-04-EKLHJH-3"],"award-info":[{"award-number":["QZX-04-EKLHJH-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40120-026-00914-2","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:34:19Z","timestamp":1773941659000},"page":"1221-1232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Intravenous Immunoglobulin in Children with Autism Spectrum Disorder with Immune Dysregulation: A Prospective, Open-Label, Single-Arm Study"],"prefix":"10.1007","volume":"15","author":[{"given":"Ziyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-2146","authenticated-orcid":false,"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"1","key":"914_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-019-0138-4","volume":"6","author":"C Lord","year":"2020","unstructured":"Lord C, et al. Autism spectrum disorder. Nat Rev Dis Primers. 2020;6(1):5.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"914_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S2215-0366(24)00363-8","volume":"12","author":"Global Burden of Disease Study Autism Spectrum, C.","year":"2025","unstructured":"Global Burden of Disease Study Autism Spectrum, C. The global epidemiology and health burden of the Autism Spectrum: findings from the Global Burden of Disease Study 2021. Lancet Psychiatry. 2025;12(2):111\u201321.","journal-title":"Lancet Psychiatry"},{"key":"914_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev-publhealth-031816-044318","volume":"38","author":"K Lyall","year":"2017","unstructured":"Lyall K, et al. The changing epidemiology of autism spectrum disorders. Annu Rev Public Health. 2017;38:81\u2013102.","journal-title":"Annu Rev Public Health"},{"issue":"10","key":"914_CR4","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1038\/s41380-022-01630-7","volume":"27","author":"M Solmi","year":"2022","unstructured":"Solmi M, et al. Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries. Mol Psychiatry. 2022;27(10):4172\u201380.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"914_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7402a1","volume":"74","author":"KA Shaw","year":"2025","unstructured":"Shaw KA, et al. Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years\u2014Autism and Developmental Disabilities Monitoring Network, 16 sites, United States, 2022. MMWR Surveill Summ. 2025;74(2):1\u201322.","journal-title":"MMWR Surveill Summ"},{"issue":"2","key":"914_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.2022.23661","volume":"329","author":"T Hirota","year":"2023","unstructured":"Hirota T, King BH. Autism spectrum disorder: a review. JAMA. 2023;329(2):157\u201368.","journal-title":"JAMA"},{"key":"914_CR7","doi-asserted-by":"publisher","first-page":"108564","DOI":"10.1016\/j.pharmthera.2023.108564","volume":"253","author":"S Salloum-Asfar","year":"2024","unstructured":"Salloum-Asfar S, Zawia N, Abdulla SA. Retracing our steps: a review on autism research in children, its limitation and impending pharmacological interventions. Pharmacol Ther. 2024;253:108564.","journal-title":"Pharmacol Ther"},{"key":"914_CR8","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1016\/j.pedn.2024.11.020","volume":"80","author":"XR Lam","year":"2025","unstructured":"Lam XR, et al. Global prevalence of depression in caregivers of children with autism: a systematic review and meta-analysis. J Pediatr Nurs. 2025;80:e74\u201385.","journal-title":"J Pediatr Nurs"},{"key":"914_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pharmthera.2018.05.007","volume":"190","author":"SR Sharma","year":"2018","unstructured":"Sharma SR, Gonda X, Tarazi FI. Autism spectrum disorder: classification, diagnosis and therapy. Pharmacol Ther. 2018;190:91\u2013104.","journal-title":"Pharmacol Ther"},{"key":"914_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065487","author":"N Usui","year":"2023","unstructured":"Usui N, Kobayashi H, Shimada S. Neuroinflammation and oxidative stress in the pathogenesis of Autism Spectrum Disorder. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24065487.","journal-title":"Int J Mol Sci"},{"key":"914_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063033","author":"MLA Robinson-Agramonte","year":"2022","unstructured":"Robinson-Agramonte MLA, et al. Immune dysregulation in Autism Spectrum Disorder: what do we know about it? Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23063033.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"914_CR12","doi-asserted-by":"publisher","first-page":"22587","DOI":"10.1038\/s41598-023-49902-8","volume":"13","author":"UTT Than","year":"2023","unstructured":"Than UTT, et al. Inflammatory mediators drive neuroinflammation in autism spectrum disorder and cerebral palsy. Sci Rep. 2023;13(1):22587.","journal-title":"Sci Rep"},{"issue":"1","key":"914_CR13","doi-asserted-by":"publisher","first-page":"12840","DOI":"10.1038\/s41598-025-98020-0","volume":"15","author":"Z Liu","year":"2025","unstructured":"Liu Z, et al. Identification of immune cells and circulating inflammatory factors associated with neurodevelopmental disorders by bidirectional Mendelian randomization and mediation analysis. Sci Rep. 2025;15(1):12840.","journal-title":"Sci Rep"},{"issue":"8","key":"914_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/1389201018666170915123700","volume":"18","author":"M Gogou","year":"2017","unstructured":"Gogou M, et al. Clinical applications of intravenous immunoglobulins in child neurology. Curr Pharm Biotechnol. 2017;18(8):628\u201337.","journal-title":"Curr Pharm Biotechnol"},{"issue":"6","key":"914_CR15","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jaip.2023.04.002","volume":"11","author":"J Bayry","year":"2023","unstructured":"Bayry J, et al. Intravenous immunoglobulin: mechanism of action in autoimmune and inflammatory conditions. J Allergy Clin Immunol Pract. 2023;11(6):1688\u201397.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"914_CR16","doi-asserted-by":"publisher","first-page":"901872","DOI":"10.3389\/fimmu.2022.901872","volume":"13","author":"C Segu-Verges","year":"2022","unstructured":"Segu-Verges C, et al. Systems biology and artificial intelligence analysis highlights the pleiotropic effect of IVIg therapy in autoimmune diseases with a predominant role on B cells and complement system. Front Immunol. 2022;13:901872.","journal-title":"Front Immunol"},{"issue":"4","key":"914_CR17","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s13311-021-01108-4","volume":"18","author":"MC Dalakas","year":"2021","unstructured":"Dalakas MC. Update on intravenous immunoglobulin in neurology: modulating neuro-autoimmunity, evolving factors on efficacy and dosing and challenges on stopping chronic IVIg therapy. Neurotherapeutics. 2021;18(4):2397\u2013418.","journal-title":"Neurotherapeutics"},{"key":"914_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11060488","author":"DA Rossignol","year":"2021","unstructured":"Rossignol DA, Frye RE. A systematic review and meta-analysis of Immunoglobulin G abnormalities and the therapeutic use of intravenous immunoglobulins (IVIG) in Autism Spectrum Disorder. J Pers Med. 2021. https:\/\/doi.org\/10.3390\/jpm11060488.","journal-title":"J Pers Med"},{"issue":"3","key":"914_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/aur.1906","volume":"11","author":"IR Melamed","year":"2018","unstructured":"Melamed IR, et al. A pilot study of high-dose intravenous immunoglobulin 5% for autism: impact on autism spectrum and markers of neuroinflammation. Autism Res. 2018;11(3):421\u201333.","journal-title":"Autism Res"},{"issue":"1","key":"914_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41398-018-0214-7","volume":"8","author":"K Connery","year":"2018","unstructured":"Connery K, et al. Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism. Transl Psychiatry. 2018;8(1):148.","journal-title":"Transl Psychiatry"},{"key":"914_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/nu15071620","author":"VN Dargenio","year":"2023","unstructured":"Dargenio VN, et al. Intestinal barrier dysfunction and microbiota-gut-brain axis: possible implications in the pathogenesis and treatment of Autism Spectrum Disorder. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15071620.","journal-title":"Nutrients"},{"key":"914_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pnpbp.2018.12.015","volume":"92","author":"FJ Castora","year":"2019","unstructured":"Castora FJ. Mitochondrial function and abnormalities implicated in the pathogenesis of ASD. Prog Neuropsychopharmacol Biol Psychiatry. 2019;92:83\u2013108.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"914_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2022.12.001","volume":"108","author":"HK Hughes","year":"2023","unstructured":"Hughes HK, Moreno RJ, Ashwood P. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD). Brain Behav Immun. 2023;108:245\u201354.","journal-title":"Brain Behav Immun"},{"key":"914_CR24","doi-asserted-by":"publisher","first-page":"1190925","DOI":"10.3389\/fimmu.2023.1190925","volume":"14","author":"M Saresella","year":"2023","unstructured":"Saresella M, et al. Alterations of natural killer cells activatory molecules phenotype and function in mothers of ASD children: a pilot study. Front Immunol. 2023;14:1190925.","journal-title":"Front Immunol"},{"key":"914_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-025-00349-z","author":"W Nour-Eldine","year":"2025","unstructured":"Nour-Eldine W, et al. A multi-omics approach reveals dysregulated TNF-related signaling pathways in circulating NK and T cell subsets of young children with autism. Genes Immun. 2025. https:\/\/doi.org\/10.1038\/s41435-025-00349-z.","journal-title":"Genes Immun"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-00914-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-00914-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-00914-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:07:28Z","timestamp":1778681248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-026-00914-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1007\/s40120-026-00914-2","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ziyan Zhang, Li Zhang, Gang Zhu, Yan Liang, Ping Pang, Huimin Yan, Xinyu Cao, Jing Wang, Xiuyu Shi, Linyan Hu, and Guang Yang declare that they have no competing interests. No financial or nonfinancial benefits have been received or will be received from any party directly or indirectly related to the subject of this study. We confirm that we have read the journal\u2019s stance on ethical publication issues and affirm that this report adheres to these guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the caregivers of all participants. The trial protocol, along with any amendments, was approved by the Ethics Committee of the Chinese PLA General Hospital (reference number S2024-826-02) and conformed to the Declaration of Helsinki guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}